These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8305223

  • 1. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases.
    Reske S, Kartsens J, Sohn M, Glöckner W, Buell U.
    Acta Oncol; 1993; 32(7-8):753-61. PubMed ID: 8305223
    [Abstract] [Full Text] [Related]

  • 2. [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].
    Reske SN, Karstens JH, Henrich MM, Sohn M, Glöckner W, Jakse G, Büll U.
    Nuklearmedizin; 1993 Jun; 32(3):111-9. PubMed ID: 8327329
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
    Zoeller G, Sandrock D, Munz DL, Ringert RH.
    Eur Urol; 1994 Jun; 26(2):141-4. PubMed ID: 7957469
    [Abstract] [Full Text] [Related]

  • 4. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
    Reske SN, Karstens JH, Glöckner WM, Ammon J, Büll U.
    Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
    Lacić M, Bokulić T, Lukac J, Kovacić K, Baum RP, Kusić Z.
    Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
    [Abstract] [Full Text] [Related]

  • 6. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
    Lee KH, Chung JK, Choi CW, Jeong JM, Lee DS, Bang YJ, Lee MC, Kim NK, Koh CS.
    J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
    [Abstract] [Full Text] [Related]

  • 7. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L.
    Anticancer Res; 1997 Oct; 17(3B):1615-8. PubMed ID: 9179204
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK, Ahn BC, Lee SW, Kim DH, Chun KA, Kim JG, Park SH, Song HS, Lee B, Lee J.
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.
    Reske SN, Karstens JH, Gloeckner W, Steinsträsser A, Schwarz A, Ammon J, Buell U.
    Lancet; 1989 Feb 11; 1(8633):299-301. PubMed ID: 2563458
    [Abstract] [Full Text] [Related]

  • 10. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
    Balaban EP, Walker BS, Cox JV, Sein AA, Abrams PG, Salk D, Sheehan RG, Frenkel EP.
    Clin Nucl Med; 1991 Oct 11; 16(10):732-6. PubMed ID: 1660386
    [Abstract] [Full Text] [Related]

  • 11. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
    Duncker CM, Carrió I, Berná L, Estorch M, Alonso C, Ojeda B, Blanco R, Germá JR, Ortega V.
    J Nucl Med; 1990 Sep 11; 31(9):1450-5. PubMed ID: 2168473
    [Abstract] [Full Text] [Related]

  • 12. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Haddock G, Gray HW, McKillop JH, Bessent RG, Kirk D.
    Br J Urol; 1989 May 11; 63(5):497-502. PubMed ID: 2731008
    [Abstract] [Full Text] [Related]

  • 13. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
    Fritz P, Adolph J, Bubeck B, Georgi P, zum Winkel K.
    Rofo; 1986 Jun 11; 144(6):689-95. PubMed ID: 3012705
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
    Bathmann J, Moser E.
    Radiologe; 1995 Jan 11; 35(1):8-14. PubMed ID: 7892445
    [Abstract] [Full Text] [Related]

  • 15. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
    Huić D, Ivancević V, Richter WS, Munz DL.
    J Nucl Med; 1997 Nov 11; 38(11):1755-8. PubMed ID: 9374347
    [Abstract] [Full Text] [Related]

  • 16. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
    Berná L, Torres G, Carrió I, Estorch M, Germá JR, Alonso C.
    Clin Nucl Med; 1994 Feb 11; 19(2):121-8. PubMed ID: 8187396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
    Otsuka N, Fukunaga M, Sone T, Yoneda M, Saito N, Tanaka H, Tomomitsu T, Yanagimoto S, Muranaka A, Morita R.
    Eur J Nucl Med; 1985 Feb 11; 11(8):319-22. PubMed ID: 4076240
    [Abstract] [Full Text] [Related]

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Feb 11; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 20. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
    Krause T, Reinhardt M, Nitzsche E, Moser E.
    Nuklearmedizin; 1999 Apr 11; 38(3):85-9. PubMed ID: 10320994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.